All In Biotech

Drug Trial Radar · NCT03623321

Extension Study of Pimavanserin in Adult Subjects With Neuropsychiatric Symptoms Related to Neurodegenerative Disease

A 52-Week Open-label Extension Study of Pimavanserin in Adult and Elderly Subjects With Neuropsychiatric Symptoms Related to Neurodegenerative Disease

Last checked: Nov 20, 2026Latest source record: Dec 20, 2024 (this record)Source: ClinicalTrials.govMethods & limitations

CompletedResults posted on the registryPivotal-lookingPhase 3. This is a heuristic, not a regulatory label.

Status

Completed

Enrollment

595

Actual

Start

Jul 17, 2018

Primary completion

May 5, 2023

Study completion May 5, 2023

Sponsor

Lead sponsor
ACADIA Pharmaceuticals Inc.Industry
Sponsor type
Industry
First posted
Aug 9, 2018

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Not applicable (single group)
Model
Single group
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 60 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

The purpose of this study is to evaluate the long-term safety and tolerability of pimavanserin in adult and elderly subjects with neuropsychiatric symptoms related to neurodegenerative disease exposed to open-label pimavanserin for up to 52 weeks.

Conditions

  • Neuropsychiatric Symptoms Related to Neurodegenerative Disease

Interventions

  • PimavanserinDrug

    • Pimavanserin 34 mg is provided as 2×17 mg tablets as single dose, once daily by mouth. Dose adjustments of pimavanserin down to 20 mg (provided as 2×10 mg tablets as a single dose, once daily by mouth) and up to 34 mg are permitted based on Investigator assessment of clinical response.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Treatment-emergent Adverse Events (TEAEs)Time frame: Treatment period and Follow-up period: 56 weeks

Locations

88 sites in 12 countries. Site status is shown where the registry gives one.

  • Cognitive Clinical Trials

    Gilbert, Arizona

  • ATP Clinical Research, Inc.

    Costa Mesa, California

  • Syrentis Clinical Research

    Santa Ana, California

  • Indago Research & Health Center Inc

    Hialeah, Florida

  • Reliable Clinical Research, LLC

    Hialeah, Florida

  • Premier Clinical Research Institute, Inc.

    Miami, Florida

  • Global Medical Institutes

    Miami, Florida

  • Future Care Solution, LLC

    Miami, Florida

  • MediClear Medical & Research Center, Inc.

    Miami, Florida

  • Novel Clinical Research LLC

    Miami, Florida

  • Laszlo J Mate, MD, PA

    North Palm Beach, Florida

  • Synexus Clinical Research US, Inc.

    The Villages, Florida

  • The NeuroCognitive Institute

    Mount Arlington, New Jersey

  • UNC Hospital

    Chapel Hill, North Carolina

  • Insight Clinical Trials LLC

    Shaker Heights, Ohio

  • Suburban Research Associates

    Media, Pennsylvania

  • Central for Biomedical Research, LLC

    Knoxville, Tennessee

  • Centre for Mental Health Prof. Dr. Ivan Temkov, Lazur Compl., Park Ezero

    Burgas, Bulgaria

  • UMHAT Psych clin for gen psychiatry and addictions

    Pleven, Bulgaria

  • DCC Sv. Vrach and Sv. Sv. Kozma and Damyan

    Sofia, Bulgaria

  • Diagnostic Consultative Centre, 2, N. Vaptzarov Street

    Varna, Bulgaria

  • Diagnostic Consultative Centre-Mladost-Psychiatry, 15, Republika Blvd.

    Varna, Bulgaria

  • Mental Health Center Vratza EOOD, 1 Belasitsa St.

    Vratsa, Bulgaria

  • Centro de Investigaciones del Sistema Nervioso

    Bogotá, Colombia

  • E.S.E. Hospital Mental de Antioquia

    Bello, Antioquia, Colombia

  • Centr Investigaciones y Proyectos en Neurociencias

    Barranquilla, Atlántico, Colombia

  • Psynapsis Salud Mental S.A.

    Pereira, Risaralda Department, Colombia

  • BRAIN-SOULTHERAPY s.r.o., Lekarna Jalta, Namesti Jana Masaryka 3113

    Kladno, Czechia

  • A-shine s.r.o./ Lekarna Centrum

    Pilsen, Czechia

  • AD71, s.r.o./Hostivarska lekarna

    Prague, Czechia

  • Axon Clinical

    Prague, Czechia

  • Neuropsychiatrie, s.r.o., Lekarna 6ka, Fajtlova 1

    Prague, Czechia

  • Petre Sarajishvili Institute of Neurology LLC

    Tbilisi, Georgia

  • Pineo Medical Ecosystem LTD

    Tbilisi, Georgia

  • Tbilisi Heart and Vascular Clinic LTD

    Tbilisi, Georgia

  • Health Institute LLC

    Tbilisi, Georgia

  • S. Khechinashvili University Hospital LLC

    Tbilisi, Georgia

  • Hospital Universitario Saltillo

    Saltillo, Coahuila, Mexico

  • Clinicos y Especialidades Medicas

    Monterrey, Nuevo León, Mexico

  • Christus Muguerza Hospital Sur

    Monterrey, Nuevo León, Mexico

Showing 40 of 88 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.